Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Diovan
Manufacturing
Sun must answer for antitrust allegations against Ranbaxy
Sun Pharma's attempt to avoid an antitrust trial has been denied by a Boston U.S. district judge. The jury trial is set for Jan. 10.
Kevin Dunleavy
Nov 24, 2021 10:06am
As recalls wear on, FDA calls 40 'sartan' meds carcinogen-free
Apr 5, 2019 11:37am
New Diovan generic approved as FDA attacks valsartan shortage
Mar 13, 2019 10:16am
EMA recalls heart drug made by Chinese firm over possible cancer risk
Jul 9, 2018 2:58pm
Sales reps, doctors to testify in Novartis kickbacks case
Mar 21, 2018 4:37pm
Novartis plant in New York bought for $18M, then resold for $30M
Sep 19, 2017 10:47am
